The Company expects to submit the New Drug Application for Xulane Lo in the second half of 2025. A low dose combination hormonal patch was found to be effective for pregnancy prevention based on ...
PITTSBURGH, May 8, 2025 /PRNewswire/ -- Viatris Inc. (VTRS) (Nasdaq: VTRS), a global healthcare company, today announced positive results of its Phase 3 study (NCT05139121) evaluating the ...
Navigating the world of birth control can be overwhelming, especially given the sheer variety of options available today. From hormonal methods like the pill and patch to long-term solutions like IUDs ...
More than 65 percent of women ages 15 to 49 in the United States use some form of birth control, and many of them are on hormonal birth control methods like the pill, patch, ring, implant, injections, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback